Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, SuperArray Bioscience

Premium

Invitrogen will launch a proteome microarray product at BIO 2004 in San Francisco this week, the company announced said. In addition, the company will detail plans for developing subsets of the human proteome with proteins grouped by family and function.


SuperArray Bioscience last week launched its RT(2) Real-Time gene expression assay kits for every gene in the human, mouse, and rat genomes. These quantitative gene expression assays are intended for genome-wide disease characterization, pathway elucidation, functional studies, and in the basic research of human disease, the company said in a statement. Additionally, the kits can be applied for the independent verification of DNA microarray data.

Each kit includes gene-specific PCR primers designed with proprietary, experimentally verified design algorithms. The PCR primers are optimized for real-time PCR and SYBR Green detection. Also included is a specially optimized master mix for real-time PCR.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.